Date: 10/13/2026. Voluntary: Firm initiated. Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
Date: 10/13/2026. Voluntary: Firm initiated. Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
Date: 10/01/2026. Voluntary: Firm initiated. Microbial Contamination of Sterile Products
Date: 08/21/2026. Voluntary: Firm initiated. Superpotent Drug
Date: 08/19/2026. Voluntary: Firm initiated. Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene
Date: 08/17/2026. Voluntary: Firm initiated. Presence of particulate matter: Particulates identified as fiberglass
Date: 08/17/2026. Voluntary: Firm initiated. Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Date: 08/12/2026. Voluntary: Firm initiated. Presence of Particulate matter.
Date: 08/11/2026. Voluntary: Firm initiated. Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
Date: 08/10/2026. Voluntary: Firm initiated. Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Date: 08/05/2026. Voluntary: Firm initiated. Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Date: 08/04/2026. Voluntary: Firm initiated. Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Date: 07/31/2026. Voluntary: Firm initiated. Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
Date: 07/24/2026. Voluntary: Firm initiated. Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
Date: 07/24/2026. Voluntary: Firm initiated. Presence of Particulate Matter
Date: 07/17/2026. Voluntary: Firm initiated. Presence of Particulate Matter; identified as stainless steel
Date: 07/17/2026. Voluntary: Firm initiated. Presence of Particulate Matter; identified as stainless steel
Date: 07/01/2026. Voluntary: Firm initiated. Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
Date: 06/24/2026. Voluntary: Firm initiated. Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.
Date: 06/04/2026. Voluntary: Firm initiated. Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.